Walgreens Boots Alliance Inc. announced on Thursday that its sales for the first quarter of fiscal 2023 came in at $33.4 billion, falling 1.5% year over year.

In addition, diluted loss per share in the first trimester stood at $4.31, as opposed to $4.13 earnings per share recorded in the same timeframe a year prior. Net loss amounted to $3.7 billion in the reported period, in comparison to net income of $3.6 billion, marked in the same quarter of 2021. The company raised its full-year sales guidance, with the figure expected to be between $133.5 billion and $137.5 billion, "reflecting Summit Health acquisition, refreshed currency rates, and first quarter sales ahead of expectations," it was noted in the report.

"Our core retail pharmacy businesses in both the United States and United Kingdom remain resilient in challenging operating environments," CEO Rosalind Brewer commented. The company's shares fell 2.45% in premarket trading following the release.